804 related articles for article (PubMed ID: 9010720)
1. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
2. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.
Jaiswal AI; Dubey C; Swain SL; Croft M
Int Immunol; 1996 Feb; 8(2):275-85. PubMed ID: 8671613
[TBL] [Abstract][Full Text] [Related]
3. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.
Wu Y; Xu J; Shinde S; Grewal I; Henderson T; Flavell RA; Liu Y
Curr Biol; 1995 Nov; 5(11):1303-11. PubMed ID: 8574588
[TBL] [Abstract][Full Text] [Related]
5. Cell-cell interactions regulate dendritic cell-dependent HIV-1 production in CD4+ T lymphocytes.
Pinchuk LM; Polacino PS; Agy MB; Klaus SJ; Clark EA
Adv Exp Med Biol; 1995; 378():461-3. PubMed ID: 8526118
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
Jaiswal AI; Croft M
J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory molecules and autoimmune thyroid diseases.
Salmaso C; Olive D; Pesce G; Bagnasco M
Autoimmunity; 2002 May; 35(3):159-67. PubMed ID: 12389640
[TBL] [Abstract][Full Text] [Related]
8. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
[TBL] [Abstract][Full Text] [Related]
10. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
Pietrella D; Lupo P; Perito S; Mosci P; Bistoni F; Vecchiarelli A
FEMS Immunol Med Microbiol; 2004 Jan; 40(1):63-70. PubMed ID: 14734188
[TBL] [Abstract][Full Text] [Related]
11. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
12. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
13. CD28 function: a balance of costimulatory and regulatory signals.
Bour-Jordan H; Blueston JA
J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
[TBL] [Abstract][Full Text] [Related]
14. Partial activation of naive CD4 T cells and tolerance induction in response to peptide presented by resting B cells.
Croft M; Joseph SB; Miner KT
J Immunol; 1997 Oct; 159(7):3257-65. PubMed ID: 9317124
[TBL] [Abstract][Full Text] [Related]
15. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
16. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
18. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
Arpinati M; Terragna C; Chirumbolo G; Rizzi S; Urbini B; Re F; Tura S; Baccarani M; Rondelli D
Exp Hematol; 2003 Jan; 31(1):31-8. PubMed ID: 12543104
[TBL] [Abstract][Full Text] [Related]
19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
20. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]